Arcutis Biotherapeutics

ARQT

Market cap $3.6B

Buy

Hold

Sell

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

Avg. target

$32

9% upside

High target

positive

1 neutral

33%

negative

Analyst & Firm	Rating	Price Target	Upside Downside	Date
Mizuho Uy Ear 33% 1-yr ARQT win rate				28 Nov ‘25 5 days ago
Goldman Sachs Richard Law				30 Oct ‘25 1 month ago
Needham Serge Belanger 71% 1-yr ARQT win rate				28 Oct ‘25 1 month ago